MI HB5077 | 2023-2024 | 102nd Legislature
Status
Spectrum: Moderate Partisan Bill (Democrat 20-3)
Status: Engrossed on April 24 2024 - 50% progression
Action: 2024-04-30 - Referred To Committee On Health Policy
Pending: Senate Health Policy Committee
Text: Latest bill text (Engrossed) [HTML]
Status: Engrossed on April 24 2024 - 50% progression
Action: 2024-04-30 - Referred To Committee On Health Policy
Pending: Senate Health Policy Committee
Text: Latest bill text (Engrossed) [HTML]
Summary
Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106.
Title
Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106.
Sponsors
Roll Calls
2024-04-24 - House - House Third Reading: Given Immediate Effect Roll Call # 39 (Y: 96 N: 11 NV: 0 Abs: 0) [PASS]
2024-03-06 - House - Reported With Recommendation Without Amendment (Y: 19 N: 0 NV: 0 Abs: 0) [PASS]
2024-03-06 - House - Reported With Recommendation Without Amendment (Y: 19 N: 0 NV: 0 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2024-04-30 | Senate | Referred To Committee On Health Policy |
| 2024-04-24 | House | Transmitted |
| 2024-04-24 | House | Passed; Given Immediate Effect Roll Call # 39 Yeas 96 Nays 11 Excused 0 Not Voting 1 |
| 2024-04-24 | House | Read A Third Time |
| 2024-04-18 | House | Placed On Third Reading |
| 2024-04-18 | House | Read A Second Time |
| 2024-03-06 | House | Referred To Second Reading |
| 2024-03-06 | House | Reported With Recommendation Without Amendment |
| 2023-10-04 | House | Bill Electronically Reproduced 10/03/2023 |
| 2023-10-03 | House | Referred To Committee On Health Policy |
| 2023-10-03 | House | Read A First Time |
| 2023-10-03 | House | Introduced By Representative Curtis Vanderwall |
